Quantitative 3D image analysis enables DCIS staging
Quantitative 3D breast image analysis of ductal carcinoma in situ (DCIS) on (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 16, 2013 Category: Radiology Source Type: news
Anastrozole may cut breast cancer risk
Conclusion
Overall, the study provides solid and believable evidence that anastrozole can reduce the number of new cases of breast cancer in postmenopausal women at higher than average risk of developing breast cancer.
The study has many strengths, including its large sample size and robust study design. However, the study also has limitations to note.
The results only apply to a specific group of postmenopausal women at a higher than average risk of developing breast cancer. "Higher risk" was defined using a number of very specific criteria. This means the results are not applicable to other groups of postmeno...
Source: NHS News Feed - December 13, 2013 Category: Consumer Health News Tags: Cancer Medication Source Type: news
New trial to help healthy women avoid unnecessary breast operations, UK
Researchers at the University of Birmingham and University Hospitals Birmingham NHS Trust are launching a breast screening study aimed at improving the treatment of ductal carcinoma in situ (DCIS) by only operating on women who need surgery - rather than all of those who show signs of abnormal cells. Many unnecessary operations including mastectomies are being performed on women who show signs of DCIS rather than cancer. DCIS means there are abnormal cells in the milk ducts. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 10, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
New test shows if DCIS breast cancer will spread
Conclusion
This research used tumour cells from 532 women to show ductal carcinoma in situ (DCIS) cells with raised levels of integrin αvβ6 were linked to the progression and recurrence of invasive breast cancer later in life.
In addition, laboratory investigations also confirmed integrin αvβ6 had tumour-promoting properties and suggested a biological mechanism to inhibit breast cancer growth linked to this molecule.
Currently breast tissue samples of women with DCIS are routinely taken to assess the biology of the early stage tumour. The implication of this research is that levels of integrin αvβ6 could be measu...
Source: NHS News Feed - December 3, 2013 Category: Consumer Health News Tags: Cancer Medical practice Source Type: news
Test could help prevent unnecessary breast cancer treatment, say scientists
Women with early stages of breast cancer may no longer face treatment without knowing whether it will become life-threateningResearchers believe they have identified a molecule that could be key to preventing over-treatment of breast cancer by revealing when the early stage of the disease is likely to develop into its invasive form.Over-diagnosis and over-treatment has become a contentious issue, provoking impassioned argument between epidemiologists. Some have gone so far as to argue that the harm caused by needless diagnosis and damaging treatment for cancerous cells that would have gone away or never progressed to disea...
Source: Guardian Unlimited Science - December 3, 2013 Category: Science Authors: Haroon Siddique Tags: The Guardian News Health Medical research & wellbeing Women Cancer Breast cancer Science Society Source Type: news
Verucca—or Something Else?
The differential diagnosis consists of psoriasis, wart, eczema, squamous cell carcinoma in situ, and prurigo nodularis. What’s your diagnosis? (Source: Consultant Live)
Source: Consultant Live - September 27, 2013 Category: Primary Care Source Type: news
Breast conserving treatment with radiotherapy reduces risk of local recurrence
Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcinoma in situ (DCIS). The incidence of DCIS has been increasing in the past decades, and this has been attributed to increased detection through breast cancer screening using mammograms. In the EORTC study, adjuvant radiotherapy after local excision reduced the incidence of both in situ and invasive local recurrences by a factor of two and resulted in an overall lower risk of mastectomy... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 20, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Breast conserving treatment with radiotherapy reduces risk of local recurrence
(European Organisation for Research and Treatment of Cancer) Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcinoma in situ. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2013 Category: Global & Universal Source Type: news
Lichenoid Keratosis
Diagnostic possibilities for this asymptomatic “red spot” included squamous cell carcinoma in-situ, superficial basal cell carcinoma, lichenoid keratosis, and insect bite. This case underscores the importance of a biopsy when the diagnosis is in doubt. (Source: Consultant Live)
Source: Consultant Live - September 11, 2013 Category: Primary Care Source Type: news
After Radiation for DCIS, No Increase in Cardiovascular Mortality, Morbidity
The exposure of the heart to radiation during radiotherapy for ductal carcinoma in situ (DCIS) did not increase cardiovascular mortality or morbidity, according to a study by researchers in the Netherlands. (Source: Cancer Network)
Source: Cancer Network - September 10, 2013 Category: Cancer & Oncology Source Type: news
MRI No Help for Breast Cancer Recurrence After DCIS
SAN FRANCISCO (MedPage Today) -- Perioperative MRI did not reduce the risk of breast cancer recurrence after treatment of ductal carcinoma in situ, a retrospective cohort study showed. (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - September 6, 2013 Category: Consumer Health News Source Type: news
MRI Does Not Improve DCIS OutcomesMRI Does Not Improve DCIS Outcomes
The use of magnetic resonance imaging has increased dramatically in American women with ductal carcinoma in situ, but a new study suggests that there is no broad benefit. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 5, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
MRI May Not Improve Outcomes for Early Form of Breast Cancer
Study found that the costly scan didn't lead to less recurrence for ductal carcinoma in situ (Source: WebMD Health)
Source: WebMD Health - September 4, 2013 Category: Consumer Health News Source Type: news
MRI May Not Improve Outcomes for Early Form of Breast Cancer
Study found that the costly scan didn't lead to less recurrence for ductal carcinoma in situ (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 4, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Gynecology, Oncology, News, Source Type: news
MRI May Not Improve Outcomes for Early Form of Breast Cancer
Study found that the costly scan didn't lead to less recurrence for ductal carcinoma in situ
Source: HealthDay
Related MedlinePlus Pages: Breast Cancer, MRI Scans (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 4, 2013 Category: Consumer Health News Source Type: news
